Birmingham, West Midlands -- (SBWIRE) -- 10/23/2013 -- Value Penny Stocks issues special report on Hovnanian Enterprises, Inc. (NYSE:HOV), IAMGOLD Corp (USA) (NYSE:IAG), Orexigen Therapeutics, Inc. (NASDAQ:OREX), Pacific Biosciences of California (NASDAQ:PACB).
Hovnanian Enterprises, Inc. (NYSE:HOV) ended its recent business day with the gain of 2.17% and closed at the price of $5.18 after opening at $5.10. The stock traded during its last trading session with the total volume of 5.01 million shares, as compared to its average volume of 4.44 million shares. Hovnanian Enterprises Inc. designs, constructs, markets, and sells residential homes in the United States. It builds garden homes, townhomes, single family homes, mid and high rise luxury homes, estate homes, adult lifestyle communities, attached and detached homes, urban infill locations, and townhomes and condominiums.
For How Long HOV will Fight for Profitability? Read This Trend Analysis report
IAMGOLD Corp (USA) (NYSE:IAG) remained among the day advancers and traded with volume of 7.73 million shares in the last session, as compared to average volume of 8.39 million shares. In comparison with 52 week range of $3.81 - $15.92, it faced lowest price of $5.12 during the last trading session whereas its day highest price was $5.30. The company’s total market capitalization is $1.97 billion, along with 376.57 million shares outstanding. IAMGOLD Corporation engages in the exploration, development, and operation of mining properties. Its products include gold, silver, niobium, and copper deposits.
For How Long IAG’s Gloss will Attract Investors? Find out via this report
Orexigen Therapeutics, Inc. (NASDAQ:OREX) showed 2.53 million shares in volume during the last trading session, while the average trading volume remained 1.15 million shares. The stock kicked off its trading session at $5.37 and closed at $5.23 after declining -2.79%. Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity.
Why Should Investors Buy OREX After the Recent Fall? Just Go Here and Find Out
Pacific Biosciences of California (NASDAQ:PACB) stock traded during its last trading session with the total traded volume of 1.18 million shares versus its average volume of 1.28 million shares. The company opened its trade at the price of $5.45 and its closing price was $5.25 after losing -2.05% for the day. Pacific Biosciences of California, Inc. develops, manufactures, and markets an integrated platform for genetic analysis. The company engages in developing a single molecule, real-time, (SMRT) technology for the detection of biological processes.
Will PACB Get Buyers Even After The Recent Rally? Find Out Here
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)